Cargando…
Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations
The high magnitude zoonotic event has caused by Severe Acute Respitarory Syndrome CoronaVirus-2 (SARS-CoV-2) is Coronavirus Disease-2019 (COVID-19) epidemics. This disease has high rate of spreading than mortality in humans. The human receptor, Angiotensin-Converting Enzyme 2 (ACE2), is the leading...
Autores principales: | Raghav, Pawan Kumar, Raghav, Aditya, Lathwal, Anjali, Saxena, Archit, Mann, Zoya, Sengar, Manisha, Rajalingam, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910265/ https://www.ncbi.nlm.nih.gov/pubmed/36759535 http://dx.doi.org/10.1038/s41598-022-20773-9 |
Ejemplares similares
-
Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects
por: Mann, Zoya, et al.
Publicado: (2022) -
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023) -
Docking‐based approach for identification of mutations that disrupt binding between Bcl‐2 and Bax proteins: Inducing apoptosis in cancer cells
por: Raghav, Pawan Kumar, et al.
Publicado: (2019) -
The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion
por: Cervantes, Marcos, et al.
Publicado: (2023) -
Are graphene and graphene-derived products capable of preventing COVID-19 infection?
por: Kumar Raghav, Pawan, et al.
Publicado: (2020)